Beam Therapeutics Inc.

NASDAQ:BEAM

24.23 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -376.742-132.527-289.088-370.638-194.592-78.326-116.738-8.002
Depreciation & Amortization 31.59320.01214.1477.4514.7353.5030.650.011
Deferred Income Tax 000-16.76563.5184.4811.7490.5
Stock Based Compensation 098.64784.32143.5715.387.0287.0020.198
Change In Working Capital 0-116.455251.628111.2545.347-10.70510.0750.74
Accounts Receivables 00300-3000000
Inventory 00-3003000000
Accounts Payables 0.834-7.5782.3730.8180.064.0922.4360.726
Other Working Capital -112.03-108.877249.255110.4365.287-14.7977.6390.014
Other Non Cash Items -2.097-18.872-38.481158.869.8712.01766.9643.846
Operating Cash Flow -347.246-149.19522.527-66.268-95.741-72.003-20.298-2.707
Investing Activities:
Investments In Property Plant And Equipment 0-33.732-48.951-46.811-16.357-12.518-13.124-0.346
Acquisitions Net 00412.3850.6283.76654.14100
Purchases Of Investments -486.439-984.338-1,616.999-777.223-282.362-130.21-0.30
Sales Maturities Of Investments 680.3921,089.911,204.614529.27198.59676.06900
Other Investing Activites -8.9460-412.385-247.953-83.766-54.141-0.30
Investing Cash Flow 185.00771.84-461.336-294.144-100.123-66.659-13.424-0.346
Financing Activities:
Debt Repayment -0.485-2.252-2.287-2.1181.6985.71400
Common Stock Issued 0270.168108.258757.449319.52837.901179.7274.984
Common Stock Repurchased 00000-25.18700
Dividends Paid 00000-12.71400
Other Financing Activities 8.2218.5325.6190.811.09648.279179.7274.984
Financing Cash Flow 7.736276.448111.59756.141322.32241.279179.7274.984
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash -154.503199.093-327.219395.729126.458-97.383146.0051.931
Cash At End Of Period 290.111444.614245.521572.74177.01150.553147.9361.931